Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

These Biotechs May Break Out While Vivus And Arena Battle It Out
Seeking Alpha
Tuesday, May 29, 2012 - 11:25am
tags:
Arena Pharmaceuticals, Vivus, YM BioSciences, Astex
ASCO Stocks To Consider This Week
Seeking Alpha
Tuesday, May 29, 2012 - 11:15am
tags:
ASCO, Arena Pharmaceuticals, Vivus, JNJ, Bayer, Onyx, Pharmacyclics
Keryx and Peers are Strong Buys
Motley Fool
Tuesday, May 29, 2012 - 11:14am
tags:
Keryx, Arena Pharmaceuticals, Dendreon, Novartis, Indenix, Spectrum Pharmaceuticals
Teva Issues 2012 Outlook
Yahoo/Zacks
Tuesday, May 29, 2012 - 11:12am
tags:
Teva Pharmaceuticals, guidance
Human Genome shareholder sues board over GSK "poison pill," Reuters reports
Yahoo/Fly on the Wall
Tuesday, May 29, 2012 - 11:11am
tags:
Human Genome Sciences, GSK, poison pill, M&A
Abbott Labs: Learn From Grace Groner
Seeking Alpha
Tuesday, May 29, 2012 - 11:10am
tags:
Abbott Laboratories, GSK, Merck, Pfizer, Novartis, Sanofi
Arena is Hands Down a Better Investment than Vivus
Motley Fool
Monday, May 28, 2012 - 11:25am
tags:
Arena Pharmaceuticals, Vivus, obesity, Qnexa, lorcaserin
Medicis Sued By Revance Therapeutics Over Wrinkle-Gel Pact
Bloomberg
Monday, May 28, 2012 - 11:22am
tags:
Medicis, ReVance
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3
Seeking Alpha
Monday, May 28, 2012 - 11:21am
tags:
ASCO, Synta, Sunesis, Arqule, Cyclacel, Aveo, Bristol-Myers Squibb
High Profitability and Low Valuation for Gilead
Motley Fool
Monday, May 28, 2012 - 11:19am
tags:
Gilead
Dr. Reddy's Laboratories Should Continue To Gain Market Share In Lucrative Markets
Seeking Alpha
Monday, May 28, 2012 - 11:17am
tags:
Dr Reddy's, India
Have J&J's Approval Hopes Vanished?
Motley Fool
Monday, May 28, 2012 - 11:16am
tags:
JNJ, bloodthinners, Xarelto
The Meaningless Drug Approval That Could Cost the Industry Billions
Motley Fool
Monday, May 28, 2012 - 11:16am
tags:
drug approvals, Pfizer, tafamidis, familial amyloid polyneuropathy
Mylan Launches Generics for Bonviva and Viramune
Yahoo/Zacks
Monday, May 28, 2012 - 11:14am
tags:
Mylan, Bonviva, generics, Europe, UK, Roche, Boehringer Ingelheim, osteoporosis, HIV, Viramune
Human Genome Shareholders Should Not Get Greedy
Seeking Alpha
Monday, May 28, 2012 - 11:11am
tags:
GSK, M&A, Human Genome Sciences
Reports: Sanofi, Merck Bid At Least $25 Per Share For Amylin
Barron's
Monday, May 28, 2012 - 11:11am
tags:
Merck, Sanofi, Amylin, M&A
Ranbaxy brings in U.S. consultants as part of consent decree
Fierce Pharma
Friday, May 25, 2012 - 11:21am
tags:
Ranbaxy, India, generics, United States, DOJ
FDA Panel Sends Mixed Message About Pfizer Drug
Pharmalot
Friday, May 25, 2012 - 11:19am
tags:
FDA, advisory panel, Pfizer, tafamidis, familial amyloid polyneuropathy
Onyx Pharma shares rise as analyst says sales of myeloma drug could reach $1B a year by 2016
Yahoo/AP
Friday, May 25, 2012 - 11:18am
tags:
Onyx, myeloma, Kyprolis
Glaxo Diabetes Drug Data Revealed Amid Hostile Takeover
Bloomberg
Friday, May 25, 2012 - 11:16am
tags:
GSK, diabetes, M&A, albiglutide, Human Genome Sciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.